Strata Critical Medical, Inc.
SRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $417,221 | $327,629 | $218,105 | $337,531 |
| - Cash | $22,753 | $58,754 | $34,830 | $18,378 |
| + Debt | $3,471 | $8,839 | $9,068 | $9,322 |
| Enterprise Value | $397,939 | $277,714 | $192,343 | $328,475 |
| Revenue | $49,298 | $70,801 | $54,306 | $54,357 |
| % Growth | -30.4% | 30.4% | -0.1% | – |
| Gross Profit | $11,614 | $17,737 | $11,978 | $12,589 |
| % Margin | 23.6% | 25.1% | 22.1% | 23.2% |
| EBITDA | -$9,238 | -$3,178 | -$5,886 | -$6,842 |
| % Margin | -18.7% | -4.5% | -10.8% | -12.6% |
| Net Income | $57,416 | -$3,743 | -$3,493 | -$9,793 |
| % Margin | 116.5% | -5.3% | -6.4% | -18% |
| EPS Diluted | 0.7 | -0.046 | -0.04 | -0.12 |
| % Growth | 1,621.7% | -15% | 66.7% | – |
| Operating Cash Flow | -$31,840 | -$4,215 | -$4,552 | $13 |
| Capital Expenditures | -$3,126 | -$2,728 | -$3,151 | -$5,042 |
| Free Cash Flow | -$34,966 | -$6,943 | -$7,703 | -$5,029 |